Olga E Makri

Dr. Olga E Makri

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2017 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
ABA. Balasopoulou
A. Balasopoulou
PΚP. Κokkinos
P. Κokkinos
DPD. Pagoulatos
D. Pagoulatos
PPPanagiotis Plotas
Panagiotis Plotas
OMOlga E Makri
Olga E Makri
Apostolos VantarakisApostolos Vantarakis
Apostolos Vantarakis
Τo perform a molecular epidemiological analysis of viral conjunctivitis among excess conjunctivitis cases recorded at the University Hospital of Patras, Greece, for the period March to June 2012. A structured questionnaire containing demographic and clinical data was developed in order to collect retrospective data on the cases. Eye swab specimens were collected and molecular detection of adenoviruses was performed by nested PCR. Positive results were confirmed by sequencing. To determine the relatedness between the isolated sequences, a phylogenetic analysis was conducted. The epidemiological analysis (including retrospective data) included 231 conjunctivitis cases (47.1% male, and 52.8% female). Based on clinical features 205 of the cases were diagnosed of viral origin (46.3% male and 53.7% female), 4 of bacterial origin (50% male and 50% female) while 22 were undefined conjunctivitis. The outbreak excess cases (included 156 cases) affected all age groups regardless gender predilection. For the positive samples indicated that 29 samples (72.5%) were AdV17, and 5 (12.5%) as AdV54. Molecular analysis could define the cause of viral conjunctivitis, while epidemiological data contributed to the assessment of the risk factors and underlined possible preventive measures. This study is one of the very few on viral conjunctivitis in Greece. This outbreak underscores the need for a national surveillance system for acute infectious conjunctivitis outbreaks. The epidemiological as well as molecular investigation on HAdV ocular infections is rather absent in Greece, which has no surveillance system for viral conjunctivitis.

3 May 2013 in Drugs
Verified
Journal Article
Closed access
PDF file
OMOlga E Makri
Olga E Makri
IGIlias Georgalas
Ilias Georgalas
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos

1 April 2016 in Experimental Eye Research
Verified
Journal Article
Closed access
AFAnastasia-Varvara Ferlemi
Anastasia-Varvara Ferlemi
OMOlga E Makri
Olga E Makri
PMPenelope G. Mermigki
Penelope G. Mermigki
Fotini N. LamariFotini N. Lamari
Fotini N. Lamari
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos

1 March 2012 in Clinical and Experimental Optometry
Verified
Journal Article
Closed access
PDF file
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos
OMOlga E Makri
Olga E Makri
PVPanagiotis Vasilakis
Panagiotis Vasilakis
AEArtemis Exarchou
Artemis Exarchou

20 March 2017 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
OMOlga E Makri
Olga E Makri
FTFoteini Tsapardoni
Foteini Tsapardoni
PPPanagiotis Plotas
Panagiotis Plotas
NINikistratos Ifantis
Nikistratos Ifantis
PXParaskevi T. Xanthopoulou
Paraskevi T. Xanthopoulou
CGConstantine D Georgakopoulos
Constantine D Georgakopoulos
Cystoid macular edema associated with latanoprost administration has been reported in patients after complicated cataract surgery with coexisting risk factors. We present the first case of preservative free latanoprost associated cystoid macular edema that occurred many months after uncomplicated cataract surgery. A 65-year old Caucasian female presented in the Outpatients Clinic complaining of reduced vision and metamorphopsia in the right eye. She had undergone uneventful phacoemulsification 19 months ago in the right eye and was under treatment with preservative free latanoprost eye drops for the last 7 months for ocular hypertension. Her remaining medical and ocular history were otherwise unremarkable. Cystoid macular edema with serous retinal detachment was diagnosed in the right eye using optical coherence tomography and fluorescein angiography. Latanoprost was discontinued and brinzolamide and nepafenac eye drops were administered in the right eye. Two months later, cystoid macular edema completely resolved with restoration of visual acuity. Nepafenac eye drops were administered for another 2 months. Eight months after latanoprost cessation optical coherence demonstrated no sign of cystoid macular edema whereas a subtle epiretinal membrane was noted. Cystoid macular edema may potentially occur in patients receiving preservative free latanoprost. More interestingly, in our case it was diagnosed in a patient with a long standing pseudophakia after uncomplicated phacoemulsification. No obvious risk factor for macular edema development was recognized. Prompt diagnosis and latanoprost discontinuation resulted in complete resolution of the cystoid macular edema and functional restoration of the eye.

30 May 2013
Verified
Journal Article
Open access
OMOlga E Makri
Olga E Makri
AFAnastasia-Varvara Ferlemi
Anastasia-Varvara Ferlemi
Fotini N. LamariFotini N. Lamari
Fotini N. Lamari
CGConstantine D. Georgakopoulos
Constantine D. Georgakopoulos
The present study sought to investigate whether Crocus sativus stigmas (saffron) extract prevents selenium-induced cataractogenesis in vivo, and to study its possible protective mechanism. Wistar rat pups were randomized into three groups. Group I (control) received subcutaneous injection of normal saline on postnatal day 10. Groups II (selenite-treated) and III (selenite+saffron-treated) received subcutaneous injection of sodium selenite (20 µmol/kg body weight) on postnatal day 10. Group III also received intraperitoneal injections of saffron extract (60 mg/kg body weight) on postnatal days 9 and 12. On postpartum day 21, rats were sacrificed and the lenses were isolated and examined for cataract formation. Activities of superoxide dismutase, glutathione peroxidase, catalase, and glutathione levels, as markers of antioxidant defense, were measured in the isolated lenses. Levels of the indicator of lipid peroxidation, malondialdehyde, and protein oxidation (sulfhydryl content) in the lens were also determined. The effect of the different treatments on lens protein profile was evaluated through an estimation of the soluble to insoluble protein ratio and sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis of the water-soluble fraction (WSF) of lens proteins. Saffron demonstrated significant protection against selenite-induced cataractogenesis in vivo. The mean activities of superoxide dismutase, glutathione peroxidase, catalase, and glutathione levels were significantly increased in group III compared to the selenite-treated group. Saffron significantly prevented selenite-induced lipid peroxidation, protein oxidation, and proteolysis and insolubilization of the lens WSF. Saffron extract prevented selenite-induced cataract formation in Wistar rats, possibly through the reinforcement of antioxidant status, reduction of the intensity of lipid peroxidation, protection of the sulfhydryl groups, and inhibition of proteolysis of the lens WSF. These findings highlight the anticataractogenic potential of saffron by virtue of its antioxidant property.